Matches in Nanopublications for { ?s ?p "[Concentration response curves to PACAP38, PACAP27, VIP and the VPAC(1) receptor agonist ([Lys15,Arg16,Leu27]-VIP[1-7]-GRF[8-27]) were constructed in the absence or presence of the PAC(1) receptor antagonist PACAP6-38 or the VPAC(1) receptor antagonist, PG97269.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP647389.RAi0vmVx4Qp9kIZ6XHCLz9fcFYfjGc5R2t1Zsf1st88Ho130_assertion description "[Concentration response curves to PACAP38, PACAP27, VIP and the VPAC(1) receptor agonist ([Lys15,Arg16,Leu27]-VIP[1-7]-GRF[8-27]) were constructed in the absence or presence of the PAC(1) receptor antagonist PACAP6-38 or the VPAC(1) receptor antagonist, PG97269.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP647389.RAi0vmVx4Qp9kIZ6XHCLz9fcFYfjGc5R2t1Zsf1st88Ho130_provenance.
- NP577981.RAY7jMm9QhaFCIfne9KtQuzCcM9A8jtzwq9QwLAKAD310130_assertion description "[Concentration response curves to PACAP38, PACAP27, VIP and the VPAC(1) receptor agonist ([Lys15,Arg16,Leu27]-VIP[1-7]-GRF[8-27]) were constructed in the absence or presence of the PAC(1) receptor antagonist PACAP6-38 or the VPAC(1) receptor antagonist, PG97269.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP577981.RAY7jMm9QhaFCIfne9KtQuzCcM9A8jtzwq9QwLAKAD310130_provenance.
- NP586513.RAODgdk3Y4ZZEluuLCv-TmMMgZbUCOApixHgmls5oIQHw130_assertion description "[Concentration response curves to PACAP38, PACAP27, VIP and the VPAC(1) receptor agonist ([Lys15,Arg16,Leu27]-VIP[1-7]-GRF[8-27]) were constructed in the absence or presence of the PAC(1) receptor antagonist PACAP6-38 or the VPAC(1) receptor antagonist, PG97269.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586513.RAODgdk3Y4ZZEluuLCv-TmMMgZbUCOApixHgmls5oIQHw130_provenance.
- NP651340.RAKUyq1Cx8ubLEs6SfMx_iypHNPoiqXl4jbNFoKema6h4130_assertion description "[Concentration response curves to PACAP38, PACAP27, VIP and the VPAC(1) receptor agonist ([Lys15,Arg16,Leu27]-VIP[1-7]-GRF[8-27]) were constructed in the absence or presence of the PAC(1) receptor antagonist PACAP6-38 or the VPAC(1) receptor antagonist, PG97269.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651340.RAKUyq1Cx8ubLEs6SfMx_iypHNPoiqXl4jbNFoKema6h4130_provenance.